Adriana Angarita-Fonseca, Anaïs Lacasse, Manon Choinière, Jean-Luc Kaboré, Marie-Pierre Sylvestre, Gillis Delmas Tchouangue Dinkou, Julie Bruneau, Marc O Martel, Richard Hovey, Aude Motulsky, Elham Rahme, M Gabrielle Pagé
PURPOSE: This study aimed to identify opioid consumption trajectories among persons living with chronic pain (CP) and put them in relation to patient-reported outcomes 6 months after initiating multidisciplinary pain treatment. METHODS: This study used data from the Quebec Pain Registry (2008-2014) linked to longitudinal Quebec health insurance databases. We included adults diagnosed with CP and covered by the Quebec public prescription drug insurance plan. The daily cumulative opioid doses in the first 6 months after initiating multidisciplinary pain treatment were transformed into morphine milligram equivalents...
January 2024: Pharmacoepidemiology and Drug Safety